IL155051A0 - Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione - Google Patents

Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione

Info

Publication number
IL155051A0
IL155051A0 IL15505101A IL15505101A IL155051A0 IL 155051 A0 IL155051 A0 IL 155051A0 IL 15505101 A IL15505101 A IL 15505101A IL 15505101 A IL15505101 A IL 15505101A IL 155051 A0 IL155051 A0 IL 155051A0
Authority
IL
Israel
Prior art keywords
thiazolidine
dione
pyridyl
ethoxy
benzyl
Prior art date
Application number
IL15505101A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL155051A0 publication Critical patent/IL155051A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15505101A 2000-09-29 2001-09-28 Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione IL155051A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0023971.5A GB0023971D0 (en) 2000-09-29 2000-09-29 Novel pharmaceutical
PCT/GB2001/004334 WO2002026735A1 (fr) 2000-09-29 2001-09-28 Sels de sodium de 5-'4-'2-(n-methyl-n-(2-pyridyl)amino) ethoxy!benzyl!thiazolidine-2,4-dione

Publications (1)

Publication Number Publication Date
IL155051A0 true IL155051A0 (en) 2003-10-31

Family

ID=9900428

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15505101A IL155051A0 (en) 2000-09-29 2001-09-28 Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione
IL188116A IL188116A0 (en) 2000-09-29 2007-12-13 Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL188116A IL188116A0 (en) 2000-09-29 2007-12-13 Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione

Country Status (27)

Country Link
US (4) US20040014752A1 (fr)
EP (2) EP1813612A1 (fr)
JP (1) JP2004509959A (fr)
KR (1) KR100917953B1 (fr)
CN (4) CN101125852A (fr)
AP (1) AP1738A (fr)
AU (2) AU2001292028B2 (fr)
BG (1) BG107679A (fr)
BR (1) BR0114308A (fr)
CA (1) CA2423975A1 (fr)
CZ (1) CZ302181B6 (fr)
DZ (1) DZ3480A1 (fr)
EA (1) EA005109B1 (fr)
EC (1) ECSP034528A (fr)
GB (1) GB0023971D0 (fr)
HU (1) HUP0301188A3 (fr)
IL (2) IL155051A0 (fr)
MA (1) MA25912A1 (fr)
MX (1) MXPA03002868A (fr)
NO (2) NO20031435L (fr)
NZ (1) NZ524933A (fr)
OA (1) OA12399A (fr)
PL (1) PL363701A1 (fr)
SK (1) SK3782003A3 (fr)
UA (1) UA74842C2 (fr)
WO (1) WO2002026735A1 (fr)
ZA (1) ZA200302439B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133637B2 (en) * 2005-10-06 2012-03-13 Headwaters Technology Innovation, Llc Fuel cells and fuel cell catalysts incorporating a nanoring support
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
RU2570424C2 (ru) * 2009-12-15 2015-12-10 МЕТАБОЛИК СОЛЮШНЗ ДЕВЕЛОПМЕНТ КОМПАНИ, ЭлЭлСи Рапп-поддерживающие тиазолидиндионы и их комбинации для лечения нейродегенеративных заболеваний

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (fr) * 1987-09-04 1998-05-20 Beecham Group Plc Thiazolidinédiones substituées
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
CN1253236A (zh) * 1998-11-11 2000-05-17 李扬远 一种以重力差释放引力能的方法
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
EA200300422A1 (ru) 2003-08-28
US20060004058A1 (en) 2006-01-05
CN1466585A (zh) 2004-01-07
EP1813612A1 (fr) 2007-08-01
WO2002026735A1 (fr) 2002-04-04
EP1332142A1 (fr) 2003-08-06
UA74842C2 (en) 2006-02-15
BR0114308A (pt) 2003-10-14
AP2003002767A0 (en) 2003-03-31
PL363701A1 (en) 2004-11-29
CN101125853A (zh) 2008-02-20
AU2001292028B2 (en) 2005-04-21
NZ524933A (en) 2004-12-24
MA25912A1 (fr) 2003-10-01
CN1915992A (zh) 2007-02-21
KR100917953B1 (ko) 2009-09-21
CA2423975A1 (fr) 2002-04-04
US20040014752A1 (en) 2004-01-22
ZA200302439B (en) 2004-04-28
US20050277679A9 (en) 2005-12-15
OA12399A (en) 2004-09-06
GB0023971D0 (en) 2000-11-15
ECSP034528A (es) 2003-05-26
US20040214866A1 (en) 2004-10-28
DZ3480A1 (fr) 2002-04-04
US20070185167A1 (en) 2007-08-09
CN101125852A (zh) 2008-02-20
BG107679A (bg) 2003-12-31
KR20030039377A (ko) 2003-05-17
SK3782003A3 (en) 2004-06-08
CN1915992B (zh) 2010-05-12
HUP0301188A2 (hu) 2003-11-28
EA005109B1 (ru) 2004-10-28
AP1738A (en) 2007-05-07
NO20076517L (no) 2003-04-29
NO20031435L (no) 2003-05-27
IL188116A0 (en) 2008-03-20
CN100345846C (zh) 2007-10-31
JP2004509959A (ja) 2004-04-02
NO20031435D0 (no) 2003-03-28
CZ2003850A3 (cs) 2004-03-17
AU9202801A (en) 2002-04-08
HUP0301188A3 (en) 2005-04-28
CZ302181B6 (cs) 2010-12-01
MXPA03002868A (es) 2004-12-06

Similar Documents

Publication Publication Date Title
DZ3316A1 (fr) Sels de chlorhydrate de 5- 4- 2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
IL146111A0 (en) 5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt
MXPA03002580A (es) Nuevas formas polimorficas de maleato de 5-(4-(2-(n-metil-n-(2-piridil) amino)etoxi)bencil) tiazolidin-2, 4-diona y proceso para su preparacion.
IL136424A0 (en) 5-[4-[2-(n-methyl-n-(2-pyridyl)amino) ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
IL136381A0 (en) Hydrate of 5-[4-[2-(n- methyl-n-(2-(pyridil)amino) ethoxy]benzyl] thiazolidine-2,4- dione maleic acid salt
IL188116A0 (en) Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
IL154724A0 (en) The hydrochloride salt of 5-[4- [2- (n-methyl-n- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione
AU6255001A (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
SI1265893T1 (sl) Hidrokloridne soli 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-diona
SI1173435T1 (en) Polymorph of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione maleic acid salt